Success Stories & Lessons Learned: TAVNEOS (Avacopan) – an Oral Inhibitor of the Complement C5a Receptor for the Treatment of ANCAAssociated Vasculitis
Time: 9:00 am
Details:
- Providing a disease and biology overview
- Sharing experiences from non-clinical and clinical development
- Addressing lessons learned from the journey
